These include tumors associated with genetic alterations in RAD51C, PALB2, BARD1, RAD51D, and CHEK2, and recent studies report that HRD could be caused by germline mutations in ATM, BAP1, CDK12, and FANCM29. Here, CHEK2 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.